Search research articles
Contact Us
Filters
Showing results (11-20 of 26) with videos related to
Page
of 3
Sort By:
Pharmacogenomics and Personalized Medicine
|
December 3, 2021
Clinical Development of AKT Inhibitors and Associated Predictive Biomarkers to Guide Patient Treatment in Cancer Medicine
Niamh Coleman, Justin T Moyers, Alice Harbery, et al.
NPJ Precision Oncology
|
January 11, 2023
Antibody-drug conjugates in lung cancer: dawn of a new era?
Niamh Coleman, Timothy A Yap, John V Heymach, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 2026
Tumor-Agnostic Therapies: Translating Scientific Breakthroughs Into Global Implementation
Jia Liu, Juliana Beal, Niamh Coleman, et al.
NPJ Precision Oncology
|
December 2, 2021
Emergence of mTOR mutation as an acquired resistance mechanism to AKT inhibition, and subsequent response to mTORC1/2 inhibition
Niamh Coleman, Vivek Subbiah, Shubham Pant, et al.
Journal of Neuro-Oncology
|
April 12, 2018
Safety, efficacy and survival of patients with primary malignant brain tumours (PMBT) in phase I (Ph1) trials: the 12-year Royal Marsden experience
Niamh Coleman, Vasiliki Michalarea, Scheryll Alken, et al.
Cancer Medicine
|
February 24, 2024
Phase I study of sapanisertib (CB-228/TAK-228/MLN0128) in combination with ziv-aflibercept in patients with advanced solid tumors
Niamh Coleman, Bettzy Stephen, Siqing Fu, et al.
Contemporary Clinical Trials
|
April 23, 2025
A Flexible Individualised ExeRcise programme for cancer patients during ChEmotherapy (FIERCE): Protocol for a randomised controlled feasibility trial
Neil Kearney, Deirdre Connolly, Katayoun Bahramian, et al.
Irish Journal of Medical Science
|
May 17, 2018
Where youth matters-clinicopathologic characteristics and emerging trends in treatment and outcomes in young Irish women with breast cancer
Megan Greally, Jennifer Kielty, Geoffrey A Watson, et al.
JCO Precision Oncology
|
January 5, 2023
<i>HRAS</i> Mutations Define a Distinct Subgroup in Head and Neck Squamous Cell Carcinoma
Niamh Coleman, Kathrina L Marcelo, Julia F Hopkins, et al.
Clinical Colorectal Cancer
|
May 3, 2017
Comparing Clinical Characteristics and Outcomes of Young-onset and Late-onset Colorectal Cancer: An International Collaborative Study
Young Soo Rho, Marine Gilabert, Karol Polom, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 26) with videos related to
Sort By:
Page
of 3
Pharmacogenomics and Personalized Medicine
|
December 3, 2021
Clinical Development of AKT Inhibitors and Associated Predictive Biomarkers to Guide Patient Treatment in Cancer Medicine
Niamh Coleman, Justin T Moyers, Alice Harbery, et al.
NPJ Precision Oncology
|
January 11, 2023
Antibody-drug conjugates in lung cancer: dawn of a new era?
Niamh Coleman, Timothy A Yap, John V Heymach, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 2026
Tumor-Agnostic Therapies: Translating Scientific Breakthroughs Into Global Implementation
Jia Liu, Juliana Beal, Niamh Coleman, et al.
NPJ Precision Oncology
|
December 2, 2021
Emergence of mTOR mutation as an acquired resistance mechanism to AKT inhibition, and subsequent response to mTORC1/2 inhibition
Niamh Coleman, Vivek Subbiah, Shubham Pant, et al.
Journal of Neuro-Oncology
|
April 12, 2018
Safety, efficacy and survival of patients with primary malignant brain tumours (PMBT) in phase I (Ph1) trials: the 12-year Royal Marsden experience
Niamh Coleman, Vasiliki Michalarea, Scheryll Alken, et al.
Cancer Medicine
|
February 24, 2024
Phase I study of sapanisertib (CB-228/TAK-228/MLN0128) in combination with ziv-aflibercept in patients with advanced solid tumors
Niamh Coleman, Bettzy Stephen, Siqing Fu, et al.
Contemporary Clinical Trials
|
April 23, 2025
A Flexible Individualised ExeRcise programme for cancer patients during ChEmotherapy (FIERCE): Protocol for a randomised controlled feasibility trial
Neil Kearney, Deirdre Connolly, Katayoun Bahramian, et al.
Irish Journal of Medical Science
|
May 17, 2018
Where youth matters-clinicopathologic characteristics and emerging trends in treatment and outcomes in young Irish women with breast cancer
Megan Greally, Jennifer Kielty, Geoffrey A Watson, et al.
JCO Precision Oncology
|
January 5, 2023
<i>HRAS</i> Mutations Define a Distinct Subgroup in Head and Neck Squamous Cell Carcinoma
Niamh Coleman, Kathrina L Marcelo, Julia F Hopkins, et al.
Clinical Colorectal Cancer
|
May 3, 2017
Comparing Clinical Characteristics and Outcomes of Young-onset and Late-onset Colorectal Cancer: An International Collaborative Study
Young Soo Rho, Marine Gilabert, Karol Polom, et al.
Page
of 3